Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125174 · ClinicalTrials.gov registry record
Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 30
- Enrollment target
NCT03125174 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants.
The verdict
NCT03125174 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Analysis of mucus, mucin and DNA concentration, MUC5B/5AC ratio, rheology, osmotic pressure, cohesion and nucleotides in sputum on 30 individual samples of good quality in healthy individuals and those with bronchiectasis. (60 total)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-10 |
| Est. Completion | 2017-06-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125174
The ClinicalTrials.gov registry entry for NCT03125174 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03125174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03125174 about?
NCT03125174 is a clinical study titled "Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls". Analysis of mucus, mucin and DNA concentration, MUC5B/5AC ratio, rheology, osmotic pressure, cohesion and nucleotides in sputum on 30 individual samples of good quality in healthy individuals and those with bronchiectasis. (60 total)
What is the current status of trial NCT03125174?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-03-10. Estimated completion is 2017-06-27.
Who is sponsoring clinical trial NCT03125174?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.